Sanofi's cholesterol drug reports positive test results
Reuters - Sat May 26, 12:16 pm ETPARIS (Reuters) - An experimental cholesterol treatment being jointly developed by Regeneron and Sanofi has shown it can lower bad cholesterol levels in difficult-to-treat patients, according to data from a mid-stage study published on Saturday. The treatment, a monoclonal antibody that works by blocking a protein called PCSK9 which preserves high bad cholesterol levels in the bloodstream, is a ...







